Development and Validation of Bio Analytical Method for Estimation of Bortezomib in k3 EDTA Human Plasma Using HPLC-ESI-MS/MS and Its Application to a Bioequivalence & CME Studies
Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 14, Issue 4
Abstract
Purpose: To develop a highly selective, reproducible & precise rugged bio analytical method for estimation of Bortezomib (BTZ), “A Protease Inhibitor” in human plasma by validating the developed method in accordance to US-FDA guidelines. Methodology Envisaged: BTZ D3 was used as an internal standard (ISTD) for the determination of BTZ in human plasma using a rapid & specific liquid chromatographic – Electron Spray Ionization –Mass spectrometric method. The analytical method was moduled with liquid-liquid phase extraction by using annular centrifugal contactor & the samples were analyzed by HPLC, on a column - ACE 5CN (150 x 4.6 mm 5 µm), using mobile phase consisting of ammonium formate buffer: ACN (25:75 v/v), delivered at 1.0 ml/min & 90% flow spitting. Applied Bio system MDS Sciex API 3000 Triple Quadruple MS equipped with Turbo Ion Spray (TIS) as LC/MS interface was used in for MS detection. TIS with multiple reaction monitoring (MRM) were acquired by ESI mass spectra, using the transitions m/z 362.95→310.21 & m/z 172.64→146.06 to quantify BTZ & BTZ D3 respectively. Results: % variability was ≤ 5.52 & ≤ 6.15 [that was ≤ 15], indicating the specificity of the method, showing no matrix interferences across the elution system. Acceptance is ranging between -8.30 to 2.83 & -4.32 to 1.00% (< 5% CV) & accuracy in the range of 92.73 – 102.20 (< 10% difference) was observed over a linear range of 2.00 – 1000 ng/mL. The mean (n=3) correlation coefficient was 0.9991 & overall mean recovery was 85.62%. Retention time for drug & ISTD is found out to be 0.08 & 0.07; % CV of area ratio is 1.91% & area ratio ≤ 2.51%, which indicated system suitability. Interpretation and Conclusion: The intended analyte is stable below 10ºC in all the performed stability experimentation & within the acceptance limits. It can be used for investigating drug concentration in routine quality control analysis in API & its pharmaceutical dosage forms.
Authors and Affiliations
Ravi Pratap Pulla, K. Vanitha Prakash, U. B. Abhini, B. Naga Maheswari, V. Divya, M. V. Shushmitha
Keywords
Related Articles
- EP ID EP342251
- DOI 10.9734/BJPR/2016/30565
- Views 125
- Downloads 0
Antimicrobial Screening and Phytochemical Analysis of Elaeis guineensis (Ewe Igi Ope) against Salmonella Strains
Aim: The study aimed at determining the in vitro anti-salmonella effect of Elaeis guineensis on Salmonella species isolated from clinically suspected typhoid fever patients in FUTA, Nigeria. Study Design: The study eval...
Gene Expression Profiling of Triple Negative Breast Cancer Cells Treated with Afatinib
Purpose: To investigate gene expression profile changes in triple negative breast cancer cells (MDA-MB-231) treated with afatinib. Methods: Differential expression of 84 genes commonly involved in breast cancer carcinog...
Effect of Formulation Variables on the Release of Letrozole from Natural Biodegradable Polymeric Implants
Aim: Letrozole, a non-steroidal aromatase inhibitor, prevents the body from producing its own estrogen. The objective of the present study was to explore the fabrication and evaluation of natural biodegradable polymeric...
Development and Validation of First Derivative Spectrophotometric Method for Quantification of Darunavir in Tablets
Aims: Darunavir is widely used in HIV/AIDS therapy. It is a HIV protease inhibitor that has excellent efficacy against the virus. The aim of this study is to develop and validate an analytical method fast and free of int...
Purification and Structure Elucidation of the Polyether Antibiotic Alborixin from Streptomyces pulcher CRF17
Aims: To screen Streptomyces sp. from saline soil in Pakistan, for its antimicrobial activity and to purify and identify the active metabolites produced by mass spectrometry and NMR spectroscopy. Strain identification by...